Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Andreas Mühler
Introduction
Andreas Mühler is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and viral infections. With a total of 6 patents to his name, Mühler's work is paving the way for new therapeutic approaches.
Latest Patents
Mühler's latest patents include innovative methods for treating multiple sclerosis using dihydroorotate dehydrogenase (DHODH) inhibitors. One notable patent describes a method of administering vidofludimus, a DHODH inhibitor, in a daily dose ranging from 10 mg to 45 mg to effectively treat or ameliorate multiple sclerosis. Another significant patent focuses on the use of vidofludimus in the treatment and prevention of viral diseases, particularly those caused by coronaviruses, including SARS-CoV-2 and its variants.
Career Highlights
Andreas Mühler is currently associated with Immunic AG, a company dedicated to developing innovative therapies for autoimmune and viral diseases. His work at Immunic AG has been instrumental in advancing research and development in these critical areas of healthcare.
Collaborations
Mühler collaborates with notable colleagues such as Daniel Vitt and Hella Kohlhof, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Andreas Mühler's contributions to medical science through his patents and collaborative efforts highlight his role as a key innovator in the treatment of complex diseases. His work continues to inspire advancements in therapeutic strategies.